Article
Targeted Molecular Therapy of GBM
1 Jan 2003
Abstract excerpt
Major advances in molecular biology, cellular biology and genomics have substantially improved our understanding of cancer. Now, these advances are being translated into therapy. Targeted therapy directed at specific molecular alterations is already creating a shift in the treatment of cancer patients. Glioblastoma (GBM), the most common brain cancer of adults, is highly suited for this new approach. GBMs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
